Equities

Equillium Inc

Equillium Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.671
  • Today's Change0.009 / 1.36%
  • Shares traded100.76k
  • 1 Year change-11.72%
  • Beta1.8189
Data delayed at least 15 minutes, as of Jul 05 2024 20:19 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • EQ:NAQ price moved over -1.41% to 0.6834
  • EQ:NAQ price rises above 15-day moving average to 0.70 at 10:54 BST
  • EQ:NAQ price rises above 15-day moving average to 0.70 at 10:38 BST
  • EQ:NAQ price rises above 15-day moving average to 0.701 at 10:40 BST

Key statistics

As of last trade, Equillium Inc (EQ:NAQ) traded at 0.671, 49.11% above the 52 week low of 0.45 set on Nov 13, 2023.
52-week range
Today
0.45Nov 13 20233.25Feb 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.67
High0.7067
Low0.6653
Bid0.6652
Offer0.6797
Previous close0.662
Average volume125.30k
Shares outstanding35.25m
Free float22.41m
P/E (TTM)--
Market cap23.34m USD
EPS (TTM)-0.3476
USD
Data delayed at least 15 minutes, as of Jul 05 2024 20:19 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.